SWOG clinical trial number
S0502

A Phase III Randomized Study of Imatinib, with or without Bevacizumab (NSC-704865), in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors

2% Accrual
Accrual
2%
Closed
Phase
2% Accrual
Accrual
2%
Published
Abbreviated Title
GIST Ph III imatinib with or without bevacizumab
Activated
04/15/2008
Closed
10/01/2009
Participants
NCORP, Members, Medical Oncologists, CTSU, Affiliates

Research committees

Gastrointestinal Cancer

Treatment

STI-571/Imatinib Bevacizumab